Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5,279 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Association between office visit intervals and long-term cardiovascular risk in hypertensive patients.
Kim D, Jeong H, Kim S, Shin HG, Park KI, Lee SP, Lee HS, Lee JY, Kim KI, Kang SH, Lee JH, Jang SY, Lee JH, Kim KH, Cho JY, Park JH, Park SK, Kim S, Kim K, Lee HY. Kim D, et al. Among authors: lee hs, lee sp, lee jy, lee jh, lee hy. J Clin Hypertens (Greenwich). 2023 Aug;25(8):748-756. doi: 10.1111/jch.14698. Epub 2023 Jul 12. J Clin Hypertens (Greenwich). 2023. PMID: 37436657 Free PMC article.
Sirolimus- vs. paclitaxel-eluting stents for the treatment of unprotected left main coronary artery stenosis: complete 2-year follow-up of a two-center registry.
Park KW, Kang SH, Park KH, Choi DH, Lee HY, Kang HJ, Cho YS, Yeon TJ, Chung WY, Koo BK, Chae IH, Choi DJ, Oh BH, Park YB, Kim HS. Park KW, et al. Among authors: lee hy. Int J Cardiol. 2011 Aug 18;151(1):89-95. doi: 10.1016/j.ijcard.2010.05.001. Epub 2010 Jun 3. Int J Cardiol. 2011. PMID: 20605240
Multicenter randomized trial evaluating the efficacy of cilostazol on ischemic vascular complications after drug-eluting stent implantation for coronary heart disease: results of the CILON-T (influence of CILostazol-based triple antiplatelet therapy ON ischemic complication after drug-eluting stenT implantation) trial.
Suh JW, Lee SP, Park KW, Lee HY, Kang HJ, Koo BK, Cho YS, Youn TJ, Chae IH, Choi DJ, Rha SW, Bae JH, Kwon TG, Bae JW, Cho MC, Kim HS. Suh JW, et al. Among authors: lee sp, lee hy. J Am Coll Cardiol. 2011 Jan 18;57(3):280-9. doi: 10.1016/j.jacc.2010.08.631. J Am Coll Cardiol. 2011. PMID: 21232664 Free article. Clinical Trial.
Cilostazol attenuates on-treatment platelet reactivity in patients with CYP2C19 loss of function alleles receiving dual antiplatelet therapy: a genetic substudy of the CILON-T randomised controlled trial.
Park KW, Park JJ, Lee SP, Oh IY, Suh JW, Yang HM, Lee HY, Kang HJ, Cho YS, Koo BK, Youn TJ, Chae IH, Choi DJ, Oh BH, Park YB, Kim HS. Park KW, et al. Among authors: lee sp, lee hy. Heart. 2011 Apr;97(8):641-7. doi: 10.1136/hrt.2010.216499. Epub 2011 Feb 22. Heart. 2011. PMID: 21345843 Clinical Trial.
Efficacy of predicting thrombotic events with combination of dual point-of-care testing (POCT) after drug-eluting stent implantation for coronary heart disease: results from the CILON-T randomized trial POCT substudy.
Lee SP, Park KW, Shin DH, Lee HY, Kang HJ, Koo BK, Suh JW, Youn TJ, Choi DJ, Chae IH, Kim HS. Lee SP, et al. Among authors: lee hy. J Atheroscler Thromb. 2011;18(10):914-23. doi: 10.5551/jat.9290. Epub 2011 Jul 26. J Atheroscler Thromb. 2011. PMID: 21791883 Free article. Clinical Trial.
Comparison between zotarolimus-eluting stents and first generation drug-eluting stents in the treatment of patients with acute ST-segment elevation myocardial infarction.
Park KW, Lim WH, Kim JH, Kang SH, Seo JW, Song YB, Hahn JY, Lee HY, Kang HJ, Cho YS, Youn TJ, Koo BK, Choi SH, Chae IH, Gwon HC, Choi DJ, Kim HS. Park KW, et al. Among authors: lee hy. Int J Cardiol. 2013 Jun 5;166(1):118-25. doi: 10.1016/j.ijcard.2011.10.012. Epub 2011 Nov 5. Int J Cardiol. 2013. PMID: 22062892
5,279 results